Clinical Trial Update: Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating short and long-term outcomes in people with multiple sclerosis treated with fampridine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampridine (4-aminopyridine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED